JP2013535445A - アルツハイマー病を治療する方法 - Google Patents

アルツハイマー病を治療する方法 Download PDF

Info

Publication number
JP2013535445A
JP2013535445A JP2013520241A JP2013520241A JP2013535445A JP 2013535445 A JP2013535445 A JP 2013535445A JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013535445 A JP2013535445 A JP 2013535445A
Authority
JP
Japan
Prior art keywords
activation
antibody against
enhancing antibody
synthase
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013520241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535445A5 (enExample
Inventor
イリイチ・エプシテイン オレグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44863153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2013535445(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/ru
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/ru
Application filed by Individual filed Critical Individual
Publication of JP2013535445A publication Critical patent/JP2013535445A/ja
Publication of JP2013535445A5 publication Critical patent/JP2013535445A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013520241A 2010-07-21 2011-07-15 アルツハイマー病を治療する方法 Pending JP2013535445A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2010130353/15A RU2542445C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2010130353 2010-07-21
RU2011127058 2011-07-01
RU2011127058/15A RU2536232C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
PCT/IB2011/002434 WO2012010978A2 (en) 2010-07-21 2011-07-15 A method of treating alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2013535445A true JP2013535445A (ja) 2013-09-12
JP2013535445A5 JP2013535445A5 (enExample) 2014-04-24

Family

ID=44863153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520241A Pending JP2013535445A (ja) 2010-07-21 2011-07-15 アルツハイマー病を治療する方法

Country Status (16)

Country Link
US (1) US20130058982A1 (enExample)
EP (1) EP2596021A2 (enExample)
JP (1) JP2013535445A (enExample)
CN (1) CN103119060A (enExample)
AU (1) AU2011281252A1 (enExample)
CA (1) CA2805943A1 (enExample)
DE (1) DE112011102409T5 (enExample)
EA (1) EA029399B1 (enExample)
FR (1) FR2962912A1 (enExample)
GB (1) GB2496801B (enExample)
IT (1) ITTO20110633A1 (enExample)
MX (1) MX2013000808A (enExample)
NZ (1) NZ606969A (enExample)
PH (1) PH12013500143A1 (enExample)
UA (1) UA107836C2 (enExample)
WO (1) WO2012010978A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
ITTO20110641A1 (it) 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizioni farmaceutiche e metodi di trattamento
US8637034B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein
EA030566B1 (ru) * 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция
CA2805963A1 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
KR20130102542A (ko) * 2010-07-21 2013-09-17 올레그 일리치 엡쉬테인 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
CN104324359B (zh) * 2014-09-25 2016-08-17 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US6451547B1 (en) * 2001-04-25 2002-09-17 Syn X Pharma Process for differential diagnosis of Alzheimer's dementia and device therefor
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
BRPI0601496B8 (pt) * 2006-04-13 2021-05-25 Miria De Amorim composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas
KR20130102542A (ko) * 2010-07-21 2013-09-17 올레그 일리치 엡쉬테인 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6015013102; 東方医学，２００７，ｖｏｌ．２３，Ｎｏ．２，ｐ．２１-３３ *
JPN6015013103; Ｂｕｌｌｅｔｉｎ　ｏｆ　Ｅｘｐｅｒｉｍｅｎｔａｌ　Ｂｉｏｌｏｇｙ　ａｎｄ　Ｍｅｄｉｃｉｎｅ，　２００９，　ｖｏｌ．１４８，　Ｎｏ．３，　Ｓｕｐｐｌ．１，　ｐ．５３３-５３５ *
JPN6015013106; Ｂｕｌｌｅｔｉｎ　ｏｆ　Ｅｘｐｅｒｉｍｅｎｔａｌ　Ｂｉｏｌｏｇｙ　ａｎｄ　Ｍｅｄｉｃｉｎｅ，　２００９，　ｖｏｌ．１４８，　Ｎｏ．２，　Ｓｕｐｐｌ．１，　ｐ．３５３-３５６ *

Also Published As

Publication number Publication date
GB201302929D0 (en) 2013-04-03
AU2011281252A1 (en) 2013-03-07
FR2962912A1 (fr) 2012-01-27
NZ606969A (en) 2015-08-28
EA201300130A1 (ru) 2013-12-30
EP2596021A2 (en) 2013-05-29
MX2013000808A (es) 2013-10-28
ITTO20110633A1 (it) 2012-01-22
WO2012010978A3 (en) 2012-04-26
CA2805943A1 (en) 2012-01-26
EA029399B1 (ru) 2018-03-30
CN103119060A (zh) 2013-05-22
GB2496801A (en) 2013-05-22
US20130058982A1 (en) 2013-03-07
PH12013500143A1 (en) 2019-09-02
WO2012010978A2 (en) 2012-01-26
UA107836C2 (uk) 2015-02-25
GB2496801B (en) 2018-04-11
DE112011102409T5 (de) 2013-07-04

Similar Documents

Publication Publication Date Title
US20130058982A1 (en) Method of treating Alzheimer's disease
KR101901465B1 (ko) 위장관의 기능적 질환 또는 상태를 치료하는 제약학적 복합 조성물 및 방법들
US8987206B2 (en) Method of treating attention deficit hyperactivity disorder
US20120258146A1 (en) Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy
JP2013532182A (ja) 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
JP2016216483A (ja) 活性化増強型抗体の効果を増大させる方法
RU2536234C2 (ru) Нейротропное лекарственное средство и способ лечения органических заболеваний нервной системы, психоорганического синдрома и энцефалопатий различного генеза
RU2536232C2 (ru) Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2542445C2 (ru) Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2526153C2 (ru) Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
RU2533224C2 (ru) Способ лечения зависимости от психоактивных веществ, алкоголизма и табакокурения и лекарственное средство для лечения зависимости от психоактивных веществ, алкоголизма и табакокурения

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150407

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150706

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151007

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160301